• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Jeff Patton on What Comes After the OCM

Video

Jeff Patton, MD, chief executive officer of Tennessee Oncology, discusses if there's concern over what comes when the Oncology Care Model (OCM) ends.

Jeff Patton, MD, chief executive officer of Tennessee Oncology, discusses if there's concern over what comes when the Oncology Care Model (OCM) ends.

Transcript

Is there concern or anticipation among providers about what might come after OCM ends?

I think less concern about what might come after OCM. It’s clear that we’re going in that direction with value, and so, we have confidence that OCM will be iterated and 2.0 will be better than 1.0 was. We have a fair amount of influence on that. I’m on the [Community Oncology Alliance] board, so I have a lot of input into the COA feedback. We also use Tuple Health as our consultants; they have the ears of CMS. I actually know, personally, the soon to be named director of CMMI, who is really smart and will give us a lot of confidence in building on the successes, and I think OCM has been a success. There are some flaws like any initial system, but we have confident that 2.0 will be better than 1.0.

What are your thoughts on COA's proposed OCM 2.0? Does it address concerns that providers have with the current model?

COA’s had a lot of input and a lot of help from Tuple and Kavita Patel, MD, to help address the flaws in the current model, but also it includes some things that should probably have been in the initial model. Again, a lot of confidence with what’s coming out of COA. I just hope we can get them to implement it.

Related Videos
Will Shapiro
Pat Van Burkleo
Jeff Stark, MD, vice president, head of medical immunology, UCB
Robert Groves, MD
Screenshot of Raajit Rampal, MD, PhD
 Laura Ferris, MD, PhD, professor of dermatology, University of Pittsburgh
Dr Padma Sripada, Columbia Internal Medicine
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
dr amy paller
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.